JBSS vs MDLZ: fair value comparison
John B. Sanfilippo & Son, Inc. and Mondelez International, Inc. · Updated 2026-10-19
JBSS currently screens as fairly valued while MDLZ screens as undervalued. Within Consumer Defensive, MDLZ currently sits closer to the top of our ranking by discount to fair value.
| JBSS | MDLZ | |
|---|---|---|
| Verdict | Fairly valued | Undervalued |
| Last price | $66.76 | $60.41 |
| 12-month range | $59.50–$90.60 | $51.51–$64.99 |
| Rank by discount to fair value | #35 of 61 Consumer Defensive | #31 of 61 Consumer Defensive |
| Quality grade | D | D |
| Leverage | Low | Moderate |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Mixed |
| DCF cross-check | — | Overvalued |
| 52-week position | The bottom quarter | The upper-middle quarter |
Full single-stock breakdowns: JBSS fair value analysis · MDLZ fair value analysis